XAIR vs LIN vs APD vs INVA vs ALB

For growth investors, Beyond Air, Inc.

(XAIR) is the stronger pick with 219. 7% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate Linde plc (LIN) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Innoviva, Inc.

(INVA) is the cheapest at 6. 9x versus Linde plc at 33. 8x. On forward P/E, Innoviva, Inc. is actually cheaper at 11. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 09x versus Innoviva, Inc. 's 1. 15x — a reasonable growth-adjusted valuation.

Over the past 5 years, Innoviva, Inc.

(INVA) delivered a total return of +94. 4%, compared to -99. 5% for Beyond Air, Inc. (XAIR). Over 10 years, the gap is even starker: LIN returned +375. 2% versus XAIR's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innoviva, Inc.

(INVA) is the lower-risk stock at 0. 13β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 1168% more volatile than INVA relative to the S&P 500. On balance sheet safety, Innoviva, Inc. (INVA) carries a lower debt/equity ratio of 23% versus 106% for Air Products and Chemicals, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Beyond Air, Inc.

(XAIR) is pulling ahead at 219. 7% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -110. 3% for Air Products and Chemicals, Inc.. Over a 3-year CAGR, INVA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innoviva, Inc.

(INVA) is the more profitable company, earning 63. 8% net margin versus -1258. 4% for Beyond Air, Inc. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus -1202. 1% for XAIR. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 09x versus Innoviva, Inc. 's 1. 15x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Innoviva, Inc. (INVA) trades at 11. 9x forward P/E versus 27. 7x for Linde plc — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INVA: 65. 2% to $37. 67.

In this comparison, APD (2.

4% yield), LIN (1. 2% yield), ALB (0. 8% yield) pay a dividend. XAIR, INVA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +375. 2% 10Y return). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, ALB: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XAIR (Healthcare) and LIN (Basic Materials) and APD (Basic Materials) and INVA (Healthcare) and ALB (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XAIR is a small-cap high-growth stock; LIN is a large-cap quality compounder stock; APD is a mid-cap quality compounder stock; INVA is a small-cap high-growth stock; ALB is a mid-cap quality compounder stock. LIN, APD, ALB pay a dividend while XAIR, INVA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.